Emboldened by the reaction to his op-ed about continuing medical education that ran in The New York Times last week, Carlat this weekend launched a site devoted to tracking the foibles surrounding CME. His essay described industry-funded CME programs as a thinly disguised form of money laundering taking place between pharma and docs.

“I want to create a clearing house for reports of blatant bias in CME programs, and also a registry of those rare CME outfits that do not accept industry money,” he tells Pharmalot about his Carlat Psychiatry Blog, not to be confused with his Psychiatry Report newsletter.

To outsiders, this topic may seem like arcane insider baseball, but CME is, in fact, a crucial piece of the pharmaceutical puzzle, one that has prompted regular criticism as a sneaky way to influence docs. As Carlat sees it, there’s a need to illuminate what he calls “dishonesty in medical education.”